Синтез мономеров полиамидных миметиков нуклеиновых кислот и исследование их свойств (1091937), страница 18
Текст из файла (страница 18)
// Eur. J. Org. Chem. – 2006. – P. 3834-3844.39.Pruzan R., Zielinska D., Rebowska-Kocon B., Nawrot B., Gryaznov S. M. Stereopureoligonucleotide phosphorothioates as human telomerase substrates. // New J. Chem. – 2010. – V.34. – P. 870-874.40.Geary R. S., Yu R. Z., Siwkowski A., Levin A. A. Pharmacokinetic/PharmacodynamicProperties of Phosphorothioate 2'-O-(2-Methoxyethyl)-Modified Antisense Oligonucleotides inAnimals and Man. In Antisense drug technology: principles, strategies, and applications. // ed.
S.T. Crooke, CRC Press. – 2008. – 2nd ed. – P. 305-326.41.Karskela M., Virta P., Malinen M., Urtti A., Lonnberg H. Synthesis and Cellular Uptakeof Fluorescently Labeled Multivalent Hyaluronan Disaccharide Conjugates of OligonucleotidePhosphorothioates. // Bioconjugate Chem. – 2008. – V. 19(12). – P. 2549-2558.42.Ushijima K., Shirakawa M., Kagoshima K., Park W.-S., Miyano-Kurosaki N., Takaku N.Anti-HIV-1 activity of an antisense phosphorothioate oligonucleotide bearing imidazole andprimary amine groups. // Biorg. Med.
Chem. – 2001. – V. 9(8). – P. 2165-2169.43.Matsukura M., Koike K., Zon G. Antisense phosphorothioates as antivirals againsthuman immunodeficiency virus (HIV) and hepatitis B virus (HBV). // Toxicology Letters. –1995. – V. 82–83 – P. 435-438.44.Wengel J., Petersen M., Frieden M., Koch T. Chemistry of Locked Nucleic Acids (LNA):Design, Synthesis and Bio-Physical Properties. In Peptide Nucleic Acids, Morpholinos andRelated Antisense Biomolecules.
// eds. C. G. Janson, M. J. During, Lands/Kluwer dualimprint/Landes series: Medical Intelligence Unit. – 2006. – P. 114-132.9145.Karkare S., Bhatnagar D. Promising nucleic acid analogs and mimics: characteristicfeatures and applications of PNA, LNA, and morpholino.
// Appl. Microbiol. Biotechnol. – 2006.– V. 71. – P. 575-586.46.Kaur H., Babu B. R., Maiti S. Perspectives on Chemistry and Therapeutic Applications ofLocked Nucleic Acid (LNA). // Chem. Rev. – 2007. – V. 107. – P. 4672-4697.47.Veedu R. N., Vester B., Wengel J. Enzymatic Incorporation of LNA Nucleotides intoDNA Strands. // ChemBioChem.
– 2007. – V. 8. – P. 490-492.48.Nagahama K., Veedu R. N., Wengel J. Nuclease resistant methylphosphonate-DNA/LNAchimeric oligonucleotides. // Bioorg. & Med. Chem. Lett. – 2009. – V. 19. – P. 2707-2709.49.Koch T., Ørum H. Locked Nucleic Acid. In Antisense drug technology: principles,strategies, and applications. // ed. S.
T. Crooke, CRC Press. – 2008. – 2nd ed. – P. 519-564.50.Varallyay E., Burgyan J., Havelda Z. Detection of microRNAs by Northern blot analysesusing LNA probes. // Methods. – 2007. – V. 43. – P. 140-145.51.Castoldi M., Benes V., Hentze M. W., Muckenthaler M. U. miChip: A microarrayplatform for expression profiling of microRNAs based on locked nucleic acid (LNA)oligonucleotide capture probes. // Methods.
– 2007. – V. 43. – P. 146-152.52.Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., HedtjärnM., Hansen H. F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E. M., Kauppinen S.LNA-mediated microRNA silencing in non-human primates. // Nature.
– 2008. – V. 452. – P.896-900.53.Kumar T. S., Wengel J., Hrdlicka P. J. 2'-N-(Pyren-1-yl)acetyl-2'-Amino-α-L-LNA:Synthesis and Detection of Single Nucleotide Mismatches in DNA and RNA Targets. //ChemBioChem. – 2007. – V. 8. – P. 1122-1125.54.Roberts J., Palma E., Sazani P., Ørum H., Cho M., Kole R. Efficient and Persistent SpliceSwitching by Systemically Delivered LNA Oligonucleotides in Mice. // Molecular therapy. –2006. – V. 14(4).
– P. 471-475.55.Summerton J. E. Morpholinos and PNAs Compared. // eds. C. G. Janson, M. J. During,Lands/Kluwer dual imprint/Landes series: Medical Intelligence Unit. – 2006. – P. 89-113.56.Iversen P. L. Morpholinos. In Antisense drug technology: principles, strategies, andapplications.
// ed. S. T. Crooke, CRC Press. – 2008. – 2nd ed. – P. 565-582.57.Youngblood D. S., Hatlevig S. A., Hassinger J. N., Iversen P. L., Moulton H. M. Stabilityof Cell-Penetrating Peptide-Morpholino Oligomer Conjugates in Human Serum and in Cells. //Bioconjugate Chem. – 2007. – V. 18. – P. 50-60.58.Amantana A., Moulton H. M., Cate M. L., Reddy M. T., Whitehead T., Hassinger J. N.,Youngblood D. S., Iversen P. L. // Pharmacokinetics, Biodistribution, Stability and Toxicity of a92Cell-Penetrating Peptide-Morpholino Oligomer Conjugate.
// Bioconjugate Chem. – 2007. – V.18. – P. 1325-1331.59.Li Y.-F., Morcos P. A. Design and Synthesis of Dendritic Molecular Transporter thatAchieves Efficient in ViWo Delivery of Morpholino Antisense Oligo. // Bioconjugate Chem. –2008. – V. 19. – P. 1464-1470.60.Fletcher S., Honeyman K., Fall A. M., Harding P. L., Johnsen R. D., Wilton S. D.Dystrophin expression in the mdx mouse after localised and systemic administration of amorpholino antisense oligonucleotide.
// J. Gene Med. – 2006. – V. 8. – P. 207-216.61.Heemskerk H. A., de Winter C. L., de Kimpe S. J., van Kuik-Romeijn P., HeuvelmansN., Platenburg G. J., van Ommen G.-J. B., van Deutekom J. C. T., Aartsma-Rus A. In vivocomparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides forDuchenne muscular dystrophy exon skipping. // J.
Gene Med. – 2009. – V. 11. – P. 257-266.62.Yokota T., Lu Q.-L., Partridge T., Kobayashi M., Nakamura A., Takeda S., Hoffman E.Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs. // Ann. Neurol.– 2009. – V. 65. – P. 667-676.63.Lupfer C., Stein D. A., Mourich D. V., Tepper S. E., Iversen P. L., Pastey M. Inhibitionof influenza A H3N8 virus infections in mice by morpholino oligomers. // Arch.
Virol. – 2008. –V. 153. – P. 929-937.64.Achim C., Armitage B. A., Ly D. H., Schneider J. W. Peptide Nucleic Acids. // Wileyencyclopedia of chemical biology. – 2008. – P. 1-10.65.Kumar V. A., Structural Preorganization of Peptide Nucleic Acids: Chiral CationicAnalogues with Five- or Six-Membered Ring Structures. // Eur. J. Org.
Chem. – 2002.– P. 20212032.66.Nielsen P. E. Peptide Nucleic Acids (PNA) in Chemical Biology and Drug Discovery. //Chemistry & Biodiversity. – 2010. – V. 7. – P. 786-804.67.Dueholm K. L., Egholm M., Behrens C., Cristensen L., Hansen H. F., Vulpius T.,Petersen K. H., Berg R. H., Nielsen P. E., Buchardt O. Synthesis of Peptide Nucleic Acidmonomers containing the four natural nucleobases: thymine, cytosine, adenine, and guanine andtheir oligomerization.
// J. Org. Chem. – 1994. – V. 59. – P. 5767-5773.68.Kosynkina L., Wang W., Liang T. C. A Convenient Synthesis Of Chiral Peptide NucleicAcid (PNA) Monomers. // Tetrahedron Letters. – 1994. – V. 35(29). – P. 5173-5176.69.Meltzer P. C., Liang A. Y., Matsudaira P. // Peptide Nucleic Acids (PNAs): Synthesis ofThymine, Adenine, Guanine, and Cytosine Nucleobase. // J. Org. Chem.
– 1995. – V. 60. – P.4305-4308.9370.Breipohl G., Will D. W., Peyman A., Uhlmann E. Novel Synthetic Routes to PNAMonomers and PNA-DNA Linker Molecules. // Tetrahedron. – 1997. – V. 53(43). – P. 1467114686.71.Falkiewicz B., Kołodziejczyk A. S., Liberek B., Wiśniewski K. Synthesis of achiral andchiral Peptide Nucleic Acid (PNA) monomers using Mitsunobu reaction. // Tetrahedron Letters.– 2001. – V.
57. – P. 7909-7917.72.Zengeya T., Li M., Rozners E. PNA containing isocytidine nucleobase: Synthesis andrecognition of double helical RNA. // Bioorg. Med. Chem. Lett. – 2011. – V. 21(7). – P. 21212124.73.Mitra R., Ganesh K. N. Aminomethylene Peptide Nucleic Acid (am-PNA): Synthesis,Regio-/Stereospecific DNA Binding, And Differential Cell Uptake of (α/γ,R/S)am-PNAAnalogues. // J. Org.
Chem. – 2012. – V. 77(13). – P. 5696-5704.74.Banerjee A., Kumar V. A. C3'-endo-puckered pyrrolidine containing PNA has favorablegeometry for RNA binding: Novel ethano locked PNA (ethano-PNA). // Bioorg. Med. Chem. –2013. – V. 21(14). – P. 4092-4101.75.Merino P., Matute R. Chemical Synthesis of Conformationally Constrained PNAMonomers. In Chemical Synthesis of Nucleoside Analogues. // ed. P. Merino, John Wiley &Sons, Inc. – 2013.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
